Given the close link between hypertension and AF, antihypertensive drugs may potentially reduce the risk of AF, especially the renin–angiotensin–aldosterone system inhibitor because of its anti-myocardial remodeling effect (Rahman et al., 2016; Seccia et al., 2017). The gene discussed is REN; the disease is atrial fibrillation.